Abstract: ObjectiveTo explore the effect of galanthamine on motor function of patients with cerebral infarction.Methods78 patients were randomly divided into the galanthamine treatment group (40 cases) and the control group (38 cases). Patients in the control group were given clinical routine treatment and rehabilitation training, while the galanthamine treatment group took galanthamine orally in addition. Evaluations were done in pre-treatment and post 6 weeks. Motor function was assessed with Fugl-Meyer motor scale (FMMS).ResultsThe increase of FMMS scores in each group had a significant difference ( P<0.05-0.01), while the process of scores in the galanthamine treatment group was superior to that in the control group (P<0.01).Conclusions Galanthamine hydrobromide is an effect drug on improving activities of motor function and ameliorating the therapeutic efficacy of rehabilitation to patients with cerebral infarction.

Key words: galanthamine, cerebral infarction, rehabilitation assessment, motor function